Janus Henderson Group PLC Has $607.25 Million Position in Corteva, Inc. $CTVA

Janus Henderson Group PLC lessened its stake in Corteva, Inc. (NYSE:CTVA) by 4.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,254,186 shares of the company’s stock after selling 354,050 shares during the period. Janus Henderson Group PLC’s holdings in Corteva were worth $607,249,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Drummond Knight Asset Management Pty Ltd bought a new stake in Corteva during the 4th quarter worth about $25,713,000. Arbejdsmarkedets Tillaegspension bought a new position in shares of Corteva in the 4th quarter valued at about $23,679,000. Leonteq Securities AG acquired a new stake in shares of Corteva during the 4th quarter worth approximately $2,350,000. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Corteva by 23.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock worth $7,378,000 after buying an additional 20,957 shares during the period. Finally, Brandes Investment Partners LP raised its stake in shares of Corteva by 1.1% during the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after buying an additional 24,985 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Up 1.8%

Corteva stock opened at $90.53 on Thursday. The firm has a market capitalization of $60.55 billion, a price-to-earnings ratio of 53.25, a PEG ratio of 2.69 and a beta of 0.56. The company’s 50 day simple moving average is $81.95 and its 200 day simple moving average is $79.41. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $90.97.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva, Inc. will post 3.76 EPS for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s dividend payout ratio is currently 42.35%.

Wall Street Analysts Forecast Growth

CTVA has been the topic of several analyst reports. Citigroup increased their price objective on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Wells Fargo & Company lifted their target price on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Royal Bank Of Canada upped their target price on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research report on Tuesday, July 21st. Zacks Research upgraded Corteva from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th. Finally, Mizuho lifted their price objective on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $90.19.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.